Tugas penyelesaian yang di minta dosen.pptx

untuk tugas

1. Serum Institute of India: COVID-19 Vaccine Pricing Summary Presentation Prepared by: [Your Name]

2. Background Serum Institute of India (SII) is the world's largest vaccine manufacturer. In response to the COVID-19 pandemic, SII embarked on developing a vaccine to address the global crisis.

3. Problems Faced 1. Pricing Uncertainty: Setting a competitive yet fair price for the COVID-19 vaccine. 2. Logistical Challenges: Ensuring efficient distribution and storage of vaccines. 3. Price Comparison: Competing with other vaccine manufacturers like Pfizer and Moderna.

4. SII Products and Innovations 1. Covishield: SII's COVID-19 vaccine developed in collaboration with AstraZeneca. 2. Production Innovations: Advanced manufacturing techniques to ensure high yield and quality.

5. Vaccine Pricing Strategy 1. Initial Price: $13 per dose, with potential reductions as economies of scale are realized. 2. Comparison: Higher than traditional vaccines by SII but competitive with global counterparts.

6. Marketing Challenges 1. Stakeholder Resistance: Convincing stakeholders to adopt the new vaccine. 2. High Initial Costs: Managing the high production and investment costs.

7. Marketing Strategies 1. Consumer Awareness Campaigns: Educating the public on the benefits of the vaccine. 2. Partnerships: Collaborating with governments and global organizations for distribution.

8. Competitive Dynamics 1. Competitors: Pfizer, Moderna, AstraZeneca, and others in the vaccine race. 2. Market Position: SII's strengths and challenges in the global vaccine market.

9. Conclusion SII's pricing strategy for Covishield aims to balance cost recovery with affordability. The company must navigate competitive pressures and logistical challenges to ensure global vaccine access.